At the time of writing, Cardlytics Inc [CDLX] stock is trading at $8.42, down -5.39%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CDLX shares have gain 3.31% over the last week, with a monthly amount glided 2.18%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Northland Capital started tracking the stock with Outperform rating on June 18, 2024, and set its price target to $14. On March 15, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $18 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $13 on November 29, 2023. Wells Fargo downgraded its rating to a Underweight and reduced its price target to $13 on September 08, 2022. Wells Fargo downgraded its rating to Equal Weight for this stock on July 14, 2022, and downed its price target to $15. In a note dated July 13, 2022, BofA Securities downgraded an Underperform rating on this stock but restated the target price of $14.
For the past year, the stock price of Cardlytics Inc fluctuated between $5.71 and $20.52. Currently, Wall Street analysts expect the stock to reach $27 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $8.42 at the most recent close of the market. An investor can expect a potential return of 220.67% based on the average CDLX price forecast.
Analyzing the CDLX fundamentals
According to Cardlytics Inc [NASDAQ:CDLX], the company’s sales were 312.48M for trailing twelve months, which represents an 5.09% jump. Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.55%, and Net Profit Margin reading is -0.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.87 and Total Capital is -0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.15 points at the first support level, and at 7.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.95, and for the 2nd resistance point, it is at 9.49.
Ratios To Look Out For
It is important to note that Cardlytics Inc [NASDAQ:CDLX] has a current ratio of 2.13. As well, the Quick Ratio is 2.13, while the Cash Ratio is 0.95. Considering the valuation of this stock, the price to sales ratio is 1.31, the price to book ratio is 2.04.
Transactions by insiders
Recent insider trading involved Gupta Amit, Chief Operating Officer, that happened on Jul 02 ’24 when 7507.0 shares were sold. Chief Financial Officer, DeSieno Alexis completed a deal on Jul 02 ’24 to sell 7451.0 shares. Meanwhile, Chief Legal & Privacy Officer Lynton Nicholas Hollmeyer sold 5956.0 shares on Jul 02 ’24.
